
Veterinary Oncology Market by Therapy (Chemotherapy, Immunotherapy, Radiology), Animal Type (Canine, Feline), Cancer Type - Global Forecast 2024-2030
Description
Veterinary Oncology Market by Therapy (Chemotherapy, Immunotherapy, Radiology), Animal Type (Canine, Feline), Cancer Type - Global Forecast 2024-2030
The Veterinary Oncology Market size was estimated at USD 390.30 million in 2023 and expected to reach USD 429.72 million in 2024, at a CAGR 10.24% to reach USD 772.77 million by 2030.
Global Veterinary Oncology Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Veterinary Oncology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Veterinary Oncology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Veterinary Oncology Market, highlighting leading vendors and their innovative profiles. These include AB Science SA, Anivive Lifesciences, Ardent Animal Health, LLC, C.H. Boehringer Sohn AG & Ko. KG, Ceva Sante Animale S.A., Covetrus, Inc., Elanco Animal Health Incorporated, ELIAS Animal Health, Fidocure, IDEXX Laboratories, Inc., Karyopharm Therapeutics Inc., Leroy Biotech S.A.S., Morphogenesis, Inc., Nippon Zenyaku Kogyo Co., Ltd., PetCure Oncology LLC, PharmAust Limited, Regeneus Ltd., Rhizen Pharmaceuticals AG, Torigen Pharmaceuticals Inc., Varian Medical Systems, Inc., Vetco Pharmaceuticals Inc., VetDC, Inc., Vetoquinol S.A., Virbac SA, VolitionRx Limited, and Zoetis Inc..
Market Segmentation & Coverage
This research report categorizes the Veterinary Oncology Market to forecast the revenues and analyze trends in each of the following sub-markets:
Therapy
Chemotherapy
Immunotherapy
Radiology
Surgery
Animal Type
Canine
Feline
Cancer Type
Lymphoma
Mammary and Squamous Cell Cancer
Mast Cell Cancer
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Veterinary Oncology Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Veterinary Oncology Market?
3. What are the technology trends and regulatory frameworks in the Veterinary Oncology Market?
4. What is the market share of the leading vendors in the Veterinary Oncology Market?
5. Which modes and strategic moves are suitable for entering the Veterinary Oncology Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
182 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Veterinary Oncology Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing Prevalence of Cancer in Pet Animals
- 5.1.1.2. Growing R&D Initiatives for Cancer Management
- 5.1.1.3. Technological Advancement in Pet Treatment
- 5.1.2. Restraints
- 5.1.2.1. High Cost of Pet Cancer Treatment
- 5.1.3. Opportunities
- 5.1.3.1. Rising Awareness Regarding Veterinary Cancer Therapies
- 5.1.3.2. Favourable Government Initiatives
- 5.1.4. Challenges
- 5.1.4.1. Adverse Effect of Drugs used for Pet Cancer Treatment
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Veterinary Oncology Market, by Therapy
- 6.1. Introduction
- 6.2. Chemotherapy
- 6.3. Immunotherapy
- 6.4. Radiology
- 6.5. Surgery
- 7. Veterinary Oncology Market, by Animal Type
- 7.1. Introduction
- 7.2. Canine
- 7.3. Feline
- 8. Veterinary Oncology Market, by Cancer Type
- 8.1. Introduction
- 8.2. Lymphoma
- 8.3. Mammary and Squamous Cell Cancer
- 8.4. Mast Cell Cancer
- 9. Americas Veterinary Oncology Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Veterinary Oncology Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Veterinary Oncology Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. AB Science SA
- 13.1.2. Anivive Lifesciences
- 13.1.3. Ardent Animal Health, LLC
- 13.1.4. C.H. Boehringer Sohn AG & Ko. KG
- 13.1.5. Ceva Sante Animale S.A.
- 13.1.6. Covetrus, Inc.
- 13.1.7. Elanco Animal Health Incorporated
- 13.1.8. ELIAS Animal Health
- 13.1.9. Fidocure
- 13.1.10. IDEXX Laboratories, Inc.
- 13.1.11. Karyopharm Therapeutics Inc.
- 13.1.12. Leroy Biotech S.A.S.
- 13.1.13. Morphogenesis, Inc.
- 13.1.14. Nippon Zenyaku Kogyo Co., Ltd.
- 13.1.15. PetCure Oncology LLC
- 13.1.16. PharmAust Limited
- 13.1.17. Regeneus Ltd.
- 13.1.18. Rhizen Pharmaceuticals AG
- 13.1.19. Torigen Pharmaceuticals Inc.
- 13.1.20. Varian Medical Systems, Inc.
- 13.1.21. Vetco Pharmaceuticals Inc.
- 13.1.22. VetDC, Inc.
- 13.1.23. Vetoquinol S.A.
- 13.1.24. Virbac SA
- 13.1.25. VolitionRx Limited
- 13.1.26. Zoetis Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. VETERINARY ONCOLOGY MARKET RESEARCH PROCESS
- FIGURE 2. VETERINARY ONCOLOGY MARKET SIZE, 2023 VS 2030
- FIGURE 3. VETERINARY ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. VETERINARY ONCOLOGY MARKET DYNAMICS
- FIGURE 7. VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
- FIGURE 8. VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
- FIGURE 10. VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
- FIGURE 12. VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.